The first members of the 2-oxoglutarate (2OG) dependent oxygenase family to be identified were prolyl and lysyl hydroxylases involved in collagen biosynthesis. Subsequently, 2OG oxygenases have been shown to catalyze oxidation reactions in most living organisms, ranging from bacteria and viruses to humans. In plants and microorganisms 2OG oxygenases catalyze many reactions employing small molecule substrates, notably involved in fatty acid metabolism and biosynthesis pathways leading to medicinally important antibiotics (antibiotic biosynthesis). One plant 2OG oxygenase, gibberellin C-20 oxidase, is the target of a commercially used herbicide and the activity of α-amino-α-cyclopropane-carboxylic acid oxidase (ACCO, the ethylene forming enzyme), an enzyme closely related to the 2OG oxygenases, is genetically regulated to control fruit ripening. 2OG oxygenases have also been the subject of study due to their involvement in genetic diseases, e.g. Ehlers–Danlos syndrome (procollagen lysyl hydroxylase) and ischemia related diseases.
There are estimated to be 60-80 human 2OG oxgenases; we aim to define roles for these enzymes at levels ranging the biochemical, i.e. what substrates they work, to the physiological. We are particularly interested in members of the family that are linked to disease, or can be targeted for the treatment of disease. Following the discovery of a role for the HIF hydroxylases in signalling, we, and others, have identified roles for 2OG oxygenases in histone and nucleic acid modification. In some cases we have linked enzyme activity, or impaired activity, to physiology, notably in the case of fat mass and obesity protein (FTO), which is a nucleic acid demethylase, and PHF8, a histone demethylase, mutations of which are linked to cleft lip/palate and mental retardation.
Major current foci for the group include the identification of selective inhibitors for histone demethylases (in collaboration with the Structural Genomics Consortium, SGC) and understanding the function in determining their substrate selectivity.
Techniques involved in this interdisciplinary research include proteomics, X-ray crystallography, biological mass spectrometry, molecular biology, kinetics and organic synthesis/medicinal chemistry.
1.
Loenarz C, Schofield CJ: Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends in Biochemical Sciences 2011, 36: 7-18.
2.
McDonough MA, Loenarz C, Chowdhury R, Clifton IJ, Schofield CJ: Structural studies on human 2-oxoglutarate dependent oxygenases. Current Opinion in Structural Biology 2010, 20: 659-672.
3.
Loenarz C, Schofield CJ: Expanding chemical biology of 2-oxoglutarate oxygenases. Nat Chem Biol 2008, 4: 152-156.
4.
Chowdhury R, Hardy A, Schofield CJ: The human oxygen sensing machinery and its manipulation. Chem. Soc. Rev. 2008, 37: 1308-1319.
5.
Flashman E, Schofield CJ: The most versatile of all reactive intermediates? Nat Chem Biol 2007, 3: 86-87.
6.
Clifton IJ, McDonough MA, Ehrismann D, Kershaw NJ, Granatino N, Schofield CJ: Structural studies on 2-oxoglutarate oxygenases and related double-stranded [beta]-helix fold proteins. Journal of Inorganic Biochemistry 2006, 100: 644-669.
7.
Schofield CJ, Ratcliffe PJ: Signalling hypoxia by HIF hydroxylases. Biochemical and Biophysical Research Communications 2005, 338: 617-626.
8.
Hewitson KS, Schofield CJ: The HIF pathway as a therapeutic target. Drug Discovery Today 2004, 9: 704-711.
1.
Loenarz C, Ge W, Coleman ML, Rose NR, Cooper CDO, Klose RJ, Ratcliffe PJ, Schofield CJ: PHF8, a gene associated with cleft lip/palate and mental retardation, encodes for an Nε-dimethyl lysine demethylase. Human Molecular Genetics 2010, 19: 217 -222.
2.
Flashman E, Hoffart LM, Hamed RB, Bollinger Jr JM, Krebs C, Schofield CJ: Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen. FEBS Journal 2010, 277: 4089-4099.
3.
Chowdhury R, McDonough MA, Mecinovic J, Loenarz C, Flashman E, Hewitson KS, Domene C, Schofield CJ: Structural Basis for Binding of Hypoxia-Inducible Factor to the Oxygen-Sensing Prolyl Hydroxylases. Structure 2009, 17: 981-989.
4.
Loenarz C, Mecinović J, Chowdhury R, McNeill LA, Flashman E, Schofield CJ: Evidence for a Stereoelectronic Effect in Human Oxygen Sensing. Angewandte Chemie International Edition 2009, 48: 1784-1787.
5.
Gerken T, Girard CA, Tung Y-CL, Webby CJ, Saudek V, Hewitson KS, Yeo GSH, McDonough MA, Cunliffe S, McNeill LA, et al.: The Obesity-Associated FTO Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase. Science 2007, 318: 1469 -1472.
6.
Ng SS, Kavanagh KL, McDonough MA, Butler D, Pilka ES, Lienard BMR, Bray JE, Savitsky P, Gileadi O, von Delft F, et al.: Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature 2007, 448: 87-91.
7.
Hewitson KS, Liénard BMR, McDonough MA, Clifton IJ, Butler D, Soares AS, Oldham NJ, McNeill LA, Schofield CJ: Structural and Mechanistic Studies on the Inhibition of the Hypoxia-inducible Transcription Factor Hydroxylases by Tricarboxylic Acid Cycle Intermediates. Journal of Biological Chemistry 2007, 282: 3293 -3301.
8.
Hewitson KS, McNeill LA, Riordan MV, Tian Y-M, Bullock AN, Welford RW, Elkins JM, Oldham NJ, Bhattacharya S, Gleadle JM, et al.: Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family. Journal of Biological Chemistry 2002, 277: 26351 -26355.
9.
Epstein ACR, Gleadle JM, McNeill LA, Hewitson KS, O’Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, et al.: C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation. Cell 2001, 107: 43-54.
10.
Wilmouth RC, Westwood NJ, Anderson K, Brownlee W, Claridge TDW, Clifton IJ, Pritchard GJ, Aplin RT, Schofield CJ: Inhibition of Elastase by N-Sulfonylaryl β-Lactams: Anatomy of a Stable Acyl−Enzyme Complex†,‡. Biochemistry 1998, 37: 17506-17513.